Curious about Fortive (FTV) Q1 Performance? Explore Wall Street Estimates for Key Metrics

Wall Street analysts forecast that Fortive (FTV) will report quarterly earnings of $0.79 per share in its upcoming release, pointing to a year-over-year increase of 5.3%. It is anticipated that revenues will amount to $1.53 billion, exhibiting an increase of 4.5% compared to the year-ago quarter.

The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.

Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

With that in mind, let's delve into the average projections of some Fortive metrics that are commonly tracked and projected by analysts on Wall Street.

Analysts predict that the 'Sales- Intelligent Operating Solutions' will reach $655.34 million. The estimate indicates a change of +3.7% from the prior-year quarter.

Analysts forecast 'Sales- Advanced Healthcare Solutions' to reach $300.17 million. The estimate points to a change of -4.1% from the year-ago quarter.

Analysts' assessment points toward 'Sales- Precision Technologies' reaching $570.79 million. The estimate indicates a year-over-year change of +10.7%.

The combined assessment of analysts suggests that 'Adjusted Operating Profit (Non-GAAP)- Intelligent Operating Solutions' will likely reach $207.88 million. The estimate is in contrast to the year-ago figure of $190.80 million.

Based on the collective assessment of analysts, 'Adjusted Operating Profit (Non-GAAP)- Advanced Healthcare Solutions' should arrive at $72.98 million. Compared to the current estimate, the company reported $64.80 million in the same quarter of the previous year.

The average prediction of analysts places 'Adjusted Operating Profit (Non-GAAP)- Precision Technologies' at $138.44 million. The estimate is in contrast to the year-ago figure of $126.90 million.

View all Key Company Metrics for Fortive here>>>

Fortive shares have witnessed a change of -7% in the past month, in contrast to the Zacks S&P 500 composite's -2.6% move. With a Zacks Rank #2 (Buy), FTV is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Top 5 Dividend Stocks for Your Retirement

Zacks targets 5 well-established companies with solid fundamentals and a history of raising dividends. More importantly, they have the resources and will to likely pay them in the future.

Click now for a Special Report packed with unconventional wisdom and insights you simply won’t get from your neighborhood financial planner.

See our Top 5 now – the report is FREE >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Fortive Corporation (FTV) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.